Improving road safety and health: Understanding kava’s impact on driver fitness by Aporosa, S. 'Apo'
                                                                                            
 
Improving road safety and health:  
Understanding kava’s impact on driver fitness  
 
 
                                                                                                                                                     
 
Dr S. ‘Apo’ Aporosa 
Te Huataki Waiora School of Health/School of Psychology’s Traffic and Road Research Group 
The University of Waikato 
 
31 July 2021 
 
Technical Report 
(Prepared for the Health Research Council of New Zealand) 







Copyright © 2021 by S. ‘Apo’ Aporosa and the Health Research Council of New Zealand 
All rights reserved. No part of this publication may be reproduced, distributed, or transmitted in 
any form or by any means, including photocopying, recording, or other electronic or mechanical 
methods, without the prior written permission of the author or the Health Research Council of 
New Zealand, except in the case of brief quotations embodied in critical reviews and certain 
other non-commercial uses permitted by copyright law. For permission requests, write to the 
author, addressed “Attention: Use permission”, at the address below. 
Dr S. ‘Apo’ Aporosa 
Te Huataki Waiora School of Health 
The University of Waikato 
Private Bag 3105  







Aporosa, S. A. (2021). Improving road safety and health: Understanding kava’s impact on driver 
fitness. Technical report prepared for (and accepted by) Health Research Council of New 







Cover photo: Todd M. Henry, 2020.  





Kava (Piper methysticum) is a traditional and culturally significant Pacific Island beverage that 
produces soporific relaxant effects. Kava use is increasing in the Pacific islands, and among Pacific 
diasporic and non-Pacific people.  
 
Users often consume the kava drink at much higher volumes than pharmacologically 
recommended doses (as much as 30 times greater is not unusual), with some users then driving 
home from kava use venues.  
 
While there has been a great deal of research using tablets (or capsules) containing selected 
extracted kavalactones, very little is understood about the psychopharmacological effects of kava 
when consumed in its natural traditionally influenced form over many hours as is typical in the 
Pacific community. 
 
Prompted by concerns over potential driver impairment as a result of kava use, this research 
involved testing the brain function of kava users over the course of a typical kava session (in terms 
of its duration and kava consumption volumes). The aim was to understand the effects that 
drinking kava had on driving safety.  
 
Participants in the active group (n=20) attended a 6-hour kava session, each drinking 3.6 litres 
(6.33 pints) of kava. A non-kava consuming control group (n=19) was also included in the study. 
At baseline, all participants were assessed with the Brain Gauge, a somatosensory tool that 
measures strategic, tactical and operational aspects of brain function. Re-testing was conducted 
after 3 hours of kava consumption, and again at the conclusion of the test period following the 
sixth hour of kava drinking.  
 
Analysis of the results compared changes in brain function, both between individuals and the 
two groups (active and control), before and after the kava drinking session. Statistical modeling 
was based on t-tests, Wilcoxon signed-rank test [W] and the Mann-Whitney U test (rank sum) 
[MW], and Bayesian analysis [BF].   
 
The results showed that, for the active participants, the kava consumed had no statistically 
significant negative impact on their Focus, Accuracy, Timing Perception, Plasticity or Fatigue, when 
compared with the control group. When active participants (kava drinkers) were compared with 
other kava users’ in their group, a slight positive increase in the kava users Focus and Fatigue was 
noted, which could infer increased driver alertness and improved driver safety.  
 




However, the negative impact of the kava on the active participants’ Temporal Order 
Judgement (“how well [the] brain is able to keep track of the order of events” which is linked to a 
participant’s executive function) was (strongly) significant at the sixth hour: [MW=0.0119; 
t=0.007301; BF=6.193058].  
 
This finding – as to the effect of kava on a person’s Temporal Order Judgement (and hence 
executive function) – is new, and suggests kava at traditionally consumed volumes compromises 
driver safety, although the nature of this impairment is vastly different to alcohol, cannabis, and 
other euphoric and hallucinogenic substances.  
 
Because executive function is also linked to Focus, Accuracy, Timing Perception, Plasticity and 
Fatigue, the finding was discussed with several psychopharmacologists, who were unable to 
provide an explanation for the anomaly, but noted that understanding of the effect of traditionally 
influenced kava consumption on cognition is still in its infancy.  
 
This study makes a new and significant contribution to understanding kava’s impacts, when 
consumed at traditional use volumes, on cognition, while also highlighting the huge knowledge 
gap that exists concerning kava psychopharmacology. The study has highlighted the need for more 
research to build understanding in this area, which would also assist road policing, particularly 
from an evidentiary perspective. The study also responded to national and international calls for 
research to fill the current gaps in understanding.  
 
Additionally, the study investigated the use of a Pacific language-friendly brochure-based driver 
awareness campaign aimed at curbing potentially unsafe post-kava drink-driving. Although well 
received, the brochure appeared to have minimal immediate impact on participants’ behavior. 
However, its value in prompting talanoa (discussion) on the subject was noted, as was the long-
term nature of driver safety awareness campaigns. 
 
The study was funded by the Health Research Council of New Zealand (19/002) and the 
University of Waikato. Cortical Metrics, the developers of the Brain Gauge, generously assisted 
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Kava drinking has been a central traditional practice of Pacific Island people for more than 2,000 
years. As Pacific people have migrated, they have taken their kava-culture with them, which has, 
in turn, influenced kava use among non-Pacific people.  
 
Many kava drinkers continue to reflect traditional patterns of use, including consuming kava at 
volumes that can be as high as 30 times the pharmacologically recommended daily dose. 
Increased kava use has also corresponded with increased reports by the police in several Pacific 
nations, New Zealand, Australia and the United States of suspected kava ‘intoxicated’ drivers.  
 
This report documents a study that used a somato-sensory tool – the Brain Gauge – to assess 
the cognitive function of 20 active kava drinkers compared with 19 control participants (non-kava 
drinkers). Testing occurred during a typical kava session conducted in a naturalistic setting, with 
the aim of understanding the potential effects that drinking kava could have on driving safety.  
 
The study was informed by two earlier investigations also aimed at understanding driver safety 
following naturalistic kava use. The historical aspects of kava use, together with kava 
psychopharmacology, the increased use of kava in new environments, road policing concerns and 
the two preceding studies will be explained before the present study and its findings are detailed.    
    
2 Background 
Kava (Piper methysticum) is the name of both the plant (a shrub) and the drink made from its roots 
and basal stump. Both the plant and the drink play an integral role in Pacific traditions and cultural 
practices (Aporosa, 2014a; 2014b; 2019b).  
 
The kava drink is not an alcohol and, when consumed, does not cause marked euphoria or 
hallucination. Rather, it induces a relaxed feeling that facilitates clear-headed discussion (Aporosa, 
2011; 2019a; Carlini, 2003). Put simply, kava's effects cannot be used as an excuse for criminal 
activity, emotional outbursts, raucousness or anti-social behavior (Aporosa, 2019a; D'Abbs, 1995). 
Kava is also considered a safe substance to ingest, lacking any major health concerns or addictive 
properties (Aporosa, 2019a; Bian et al., 2020). 
 
Within kava, lipid-soluble kavalactones (Sarris, LaPorte, & Schweitzer, 2011) produce analgesic 
(Singh, 1992), antithrombotic, hypnotic, sedative (Cairney, Maruff, & Clough, 2002), anxiolytic 
(Pittler & Ernst, 2003; Singh & Singh, 2002) and muscle relaxant (Duffield & Jamieson, 1988) 
psychoactive effects. These effects are attributed to kava’s action in the central nervous system, 
where it is understood to decrease neurotransmitter function (Carlini, 2003; Ligresti et al., 2012; 
Lim, 2016). 




In 1989, Saletu and colleagues reported that a single 200mg tablet dose of kavain – one of the 
six key kavalactones found in kava – has an “elimination half-life of 9 hours” (p. 188). Based on 
this work, Aporosa (2008) calculated that it took slightly more than 90 hours for kava to be 
eliminated from the body (p. 46). Work to further understand kava’s elimination half-life has 
stalled since Aporosa’s work (National Standard, 2010). However, some commentators have 
suggested this half-life may be longer than 9 hours, particularly when kava is consumed at 
traditional high volumes and when all of the kavalactones – currently understood to number 20 
(Bian et al., 2020) – are present. 
 
Elsewhere, kava has been reported as a safe, non-addictive and viable alternative to 
benzodiazapam for the treatment of generalised anxiety disorder (Sarris et al., 2013). That safe 
status is reflected in kava’s regulation in New Zealand – falling under the Food Standards Code 
2015 (New Zealand Government, 2015) – which classifies kava as a ‘food’. Additionally, the World 
Health Organization’s 2016 kava risk assessment states, "On balance, the weight-of-evidence from 
both a long history of use of kava beverage and from the more recent research findings indicates 
that it is possible for kava beverage to be consumed with an acceptably low level of health risk" 
(Abbott, 2016, p. 26).  
 
Kava’s psychotropic properties have also made it increasingly popular among non-Pacific 
people outside of the Pacific islands and within Pacific diasporic communities (Aporosa, 2015; 
Aporosa & Forde, 2017; Sumampow & Henry, 2021; Tecun, 2021), where, in some countries, kava 
is served in bar-like settings as an alternative to alcohol (Blackwood, 2019; Showman et al., 2015; 
Tecun, Reeves, & Wolfgramm, 2020; Wolinski, 2018). Although kava use among women is 
common in Fiji, this is not the case in all Pacific nations. However, as kava has moved into diasporic 
spaces, this has seen a dramatic increase in its use by Pacific women, with women drinking in both 
mixed gender and women only environments (Lolohea, 2021; Tecun et al., 2020). 
 
2.1 Traditionally influenced kava consumption 
For the purpose of this report, kava is defined as the drink resulting from mixing kava rhizome 
with water, and consumed in a naturalistic and traditionally influenced setting, alongside 
established cultural practices, as explained here. It does not include tablets or capsules containing 
selected extracted kavalactones, or pop-culture drinks containing flavoured or commercially 
produced and bottled kava. 
 
Kava, when consumed in traditionally influenced settings is made by steeping dried and 
pounded kava rhizome in water in a kumete (a traditional wooden kava bowl). The resulting drink 
is then served to those present in bilo or ipu (cups made from half coconut shells) (see Figure 1). 
 












Figure 1: Mixing kava in a kumete (kava bowl) in Auckland, New Zealand (photographer: Todd M. Henry, 2019). 
 
Drinkers typically sit cross-legged on mats on the floor, observe cultural etiquette including a 
serving order based on hierarchy, partake in cobo (clapping) before drinking and after, and engage 
in talanoa or culturally guided discussion underpinned by Pacific respect-based values (Aporosa, 
2014a) (see Figure 2).  
 
 
Figure 2: Kava drinking by participants with mixed ethnicity in a private home (Māori owners) in Waikato, New 
Zealand (photographer: Author, 2009). 
 
Aporosa and Tomlinson (2014) report that traditionally influenced Fijian kava drinking sessions 
(in Fiji) last, on average, for over 6 hours. During this time, consumers will typically ingest 3.6 litres 
(6.33 pints) of aqueous kava. Depending on the age of the kava plant at the time of harvest 
(lactone levels increase with age) and the concentration of the kava when mixed into the 
beverage, consumers often ingest more than 8,000mg of kavalactones per sitting, which 
represents 30 times the pharmacologically recommended daily dose. 
 
2.2 Kava use and driver safety 
The increased use of kava outside of the Pacific islands and kava’s documented psychoactive 
properties have raised questions about its impact on cognitive functions, particularly in relation 
to driver safety.  
 




The New Zealand Police, for example, report stopping increased numbers of drivers who 
appear mildly intoxicated, although breath-screening tests return negative results, with officers 
suspecting kava impairment (Morgan, 2014; 2017; Tokalau, 2020; Welsh, 2017). Australian police 
also report a suspected link between kava use and an increased likelihood of serious motor vehicle 
accidents (Fu et al., 2019). Researchers in Iowa in the United States report “kava impairment was 
demonstrated through four cases of self-reported kava use … [suggesting kava use] may hinder 
one’s ability to operate a vehicle safely” (Berry, Gilbert, & Grodnitzky, 2019, p. 1948).  
 
In addition, the New Zealand Institute of Environmental Science and Research (New Zealand’s 
Crown research institute) reports increased detection of kavalactones in the blood of deceased 
motor vehicle accident victims (Poulsen et al., 2012). However, the institute acknowledges there 
are large knowledge gaps concerning the interpretation of kavalactones in the blood. For instance, 
at this stage, it is not possible to determine whether kavalactones detected in the blood of victims 
result from kava consumed in the previous hour, or previous 24 hours or even 36 hours (Poulsen 
& McCarthy, 2020).  
 
With kava not metabolising on the breath in a similar manner to alcohol, and therefore not 
allowing breath screening, and with blood testing of suspected kava drink-drivers being 
ineffectual for evidential purposes, the monitoring and policing of kava-impaired drivers is 
extremely difficult.  
 
This difficulty is illustrated in a recent news item by journalist Torika Tokalau (2020). Tokalau 
reported that shortly after 2am on 14 October 14, 2018, New Zealand Police stopped a driver 
whose actions led them to believe he was under the influence of alcohol or drugs. The 52-year-
old male driver admitted to consuming “about five or six small bowls [bilo or ipu]” of kava and 
also taking an “unknown prescription medicine” for leg and back issues. After passing a breath-
screening test, he was ordered to undergo a roadside coordination test to determine his sobriety. 
He was subsequently arrested and charged with "driving while incapable”, due to a perceived 
unsteadiness on his feet. The case took 14 months to process through the court system, with the 
driver eventually found not guilty due to “reasonable doubt”; as it could not be determined 
whether the unsteadiness was the result of kava, the prescription medicine, a combination of 
both, or the leg and back issues.  
 
While this report is not suggesting kava consumption by the driver was the cause of his 
unsteadiness, the title of Tokalau’s article – “Auckland man under the influence of kava gets off 
drug-driving charge” – appears to insinuate this, with the clear inference that he was ‘under the 
influence’ and yet ‘got off’ the drug-driving charge.  
 




This current lack of a suitable evidentiary standard measure, against which to assess driver 
competency following kava use, not only impedes road policing efficiency and road safety, but 
also judicial process and the protection of innocents where applicable. Further, this lack of a 
suitable measure is evidenced in the fact that, to date, there has only been one successful kava-
use-related driving prosecution in New Zealand (DCNZ, 2000; Tokalau, 2020), and a small number 
overseas (Swenson, 1996; Jolly, 2009).  
 
The prevalence of people driving while under the influence of drugs or alcohol is a significant 
health and safety issue in New Zealand, with an estimated annual ‘social cost’ of $564 million 
(Ministry of Transport, 2017, p. 4).  In one recent New Zealand study, 20 per cent of drivers 
reported taking drugs known to interfere with driver safety within 3 hours of driving (Starkey et 
al., 2016). In Australia, research focused specifically on Tongan kava drinkers, reported that it was 
common for 70 per cent of participants to drive home from kava drinking sessions (Maneze et al., 
2008); travel that can include long-distance and inter-city driving (Aporosa, 2018b). By applying 
this estimate to the reported 20,000 people in New Zealand who drink kava on an average Friday 
or Saturday night (Aporosa, 2015), this would suggest there could be as many as 14,000 kava users 
controlling motor vehicles over this time.  In addition, injury due to road traffic accidents is the 
leading cause of hospitalisation for Pacific men and women in New Zealand (Slack et al., 2009). 
Hospitalisation due to drug use is also higher among Pacific people than the general population, 
and increases significantly with age (Slack et al., 2009).    
 
Rosekind and colleagues (2020) point out the need for more research aimed at understanding 
the effects that drug substances, notably substances other than alcohol and cannabis, have on 
driver safety. They also acknowledge that these studies can be complicated, requiring new and 
innovative approaches, particularly “in today’s world of poly drug-impaired drivers” (p. E1).  
 
It should be noted that although kava is regulated as a ‘food’ in New Zealand, kava is 
nevertheless a ‘drug’.  The World Health Organization (2021) explains that any substance, “when 
taken in or administered into one's system, [which] affect[s] mental processes, e.g. perception, 
consciousness, cognition or mood and emotions” is a drug. This includes nicotine, coffee, energy 
drinks such as Red Bull, and kava. As the World Health Organization goes on to explain, this can 
be confusing, as the term ‘drug’ is often incorrectly associated with “dependence-producing … 
‘drug use’, ‘substance use’ or ‘substance abuse’.” Therefore, had the 52-year-old male driver in 
Torika Tokalau’s (2020) article been convicted in court, he would have been guilty of drug-driving.  
  
2.3 Kava use and cognitive function 
LaPorte and colleagues (2011) present the first comprehensive literature review on kava’s effect 
on cognitive function. While this is valuable, overall the findings show inconsistency and 




subjectivity across the studies surveyed. This was best illustrated in a 2017 update of the review, 
which included only one new study since 2011.  
 
Sarris and McIntyre (2017) report that of 12 clinical trials that assessed the effects of kava on 
‘mental function’, four reported “improved accuracy and performance on visual attention and 
working memory”, five showed “kava to have little or no negative effect on cognitive processes”, 
while another “reported kava to impair reaction time” (p. 16). 
 
It is important to note that these studies involved participants who had consumed a modified 
version of kava, taken in tablet (or capsule) form. Administered at a pharmaceutically 
recommended “daily dose of 60–250mg kavalactones” (Bian et al., 2020, p. 13), these tablets 
contain selected extracted kavalactones, which Bian and colleagues (2020) refer to as “designer 
kava preparations” (p. 23). Such preparations are vastly different to kava consumed in naturalistic 
traditionally influenced settings. This contrast between modified pill-style kava and naturalistic 
kava has led some researchers to question whether the former can rightly be called or considered 
to be actual kava (Aporosa, 2019a). Moreover, it is common for findings deriving from research 
that used modified pill-style kava to be applied to, and overlaid on, naturalistic kava use 
psychopharmacology, incorrectly assuming affect correlation.  
 
Bwarenaba et al. (2017) report that kavalactone “modes of action are not fully understood” 
(p. 1) and even less is understood about “the neurophysiological mechanisms associated with 
kavalactone metabolism” (p. 5). When this finding is considered alongside the fact that most 
research into kava’s effects on cognitive function have used modified kava in tablet or capsule 
form, plus the dearth of equivalent research based on naturalistic kava use, these gaps in 
understanding become even more pronounced.  
 
There is a real need for experimental data that investigates the cognitive effects of kava 
consumed in naturalistic settings at traditional volumes (Abbott, 2016, p.viii; Bian et al., 2020, p. 
23). Such data will be valuable for understanding kava’s effect on driver safety, which in turn could 
provide insights into the over-representation of Pacific people in motor vehicle accidents.   
 
2.4 Initial research into the cognitive impacts of kava when consumed at traditional volumes 
The first study that aimed to understand kava’s impacts on cognition, and in turn driver safety, 
both during and following its consumption at traditional volumes, started in 2017 and was funded 
by a Health Research Council of New Zealand Pacific post-doctoral award (ref. 16/462).  




This study, referred to as Experiment 1, used two visual-sensory psychometric measures drawn 
from the Vienna Test System: Traffic test battery. These were the WAFA1 Alertness and WAFG 
Divided Attention measures (Strum, 2011a; 2011b). The measures are industry standard 
assessments of driver safety and have been used extensively to assess the impacts of drugs and 
alcohol on driving. 
 
The results of Experiment 1 failed to identify statistically significant differences in cognitive 
function between a control (non-kava drinking, n=20) and active (kava drinking, n=20) group 
following kava consumption (Aporosa, 2018a). However, the study investigators observed that 
most of the active participants exhibited a slowed motor response and a slight slurring of speech, 
which started around the mid-point of testing, or after 3 hours of kava consumption (Aporosa, 
2017b). 
 
This anomaly – between the lack of a test-identified impairment in cognitive function and the 
observed deterioration – was discussed with several psychopharmacology experts. The experts 
postulated that the experiment’s failure to detect a significant difference in cognitive function was 
potentially due to the Vienna Test System measures using visual-sensory assessment, whereas 
kava’s dominant action is to decrease neurotransmitter function in the central nervous system 
(Aporosa, 2020; Aporosa, Atkins, & Brunton, 2020). They suggested an alternative assessment tool 
could be used; one capable of measuring subtle changes in cognition via the central nervous 
system.  
 
This alternative testing system – named the Brain Gauge – was assessed in a feasibility study 
also funded by the Health Research Council of New Zealand Pacific post-doctoral award (ref. 
16/462). That feasibility study is discussed in detail in a recently published paper in Pacific 
Dynamics: Journal of Interdisciplinary Research (Aporosa, Atkins & Leov, 2021), where it is argued 
that the methodology and methods used in the study “provide a robust procedure for examining 
the effects of kava on cognitive function in the context of a full study, while maintaining the 
naturalistic setting of a traditional kava session.” (p. 82)  
 
Learning from the feasibility study was then used to inform a new application to the Health 
Research Council. This resulted in the 2019 New Zealand Health Research Council: Pacific Sir 
Thomas Davis Te Patu Kite Rangi Ariki Award (ref. 19/002) being awarded to the author, enabling 
the feasibility study to be replicated in a full research study. This report describes and explains 
that full study. 
 
 
1 WAFA and WAFG are test labels and not acronyms. 




2.5 Study aims and hypothesis  
The study described in this report aimed to measure aspects of participants’ neurological 
functioning during, and immediately following, traditionally influenced kava consumption, and to 
apply those results to driver functionality.  
 
The purpose was to build better understanding of kava-related cognition, driver safety and 
coordination issues. It is anticipated this information will improve road safety, reduce injury and 
hospitalisation rates, and the related economic and social costs, and have a positive impact on the 
health of Pacific people and other road users, both in New Zealand and internationally.  
 
The hypothesis being tested was that the participants consuming kava in the active kava using 
group would show changes in their neurological functioning (namely speed, focus, fatigue, 
accuracy, sequencing, timing perception, plasticity and connectivity), when compared with the 
participants not consuming kava in the control group.   
 
 
3 Methodology and methods 
The study was based at the University of Waikato’s Te Huataki Waiora School of Health and linked 
to the School of Psychology’s Traffic and Road Safety Research Group. Ethics approval was granted 
by the Health and Disability Ethics Committee within the New Zealand Ministry of Health 
(reference number 19/NTB/44).  
 
The study was guided by the post-development methodological framework and the faikava 
methodology.  
 
The post-development methodological framework combines the Fijian vanua research 
framework with post-development theory, to guide the ethical and equitable use of Western-
developed, -standardised and -normed psychometric measures among Pacific peoples (Aporosa, 
2014a, p. 102; Aporosa et al., 2021). It is also argued that the framework has broader applicability 
for all ethnicities, as it is underpinned by ideals and values based on respect; ensuring participants 
are treated with dignity and respect at all times, and that the guests and their needs are treated 
as superior to those of the host (or research team).  
 
The faikava methodology uses a naturalistic kava-use environment to collect both quantitative 
and qualitative research data. This approach to data collection has only recently been termed the 
faikava methodology, although these types of naturalistic settings have been used for research 
purposes for more than 20 years. The faikava methodology is endorsed by the Health Research 




Council (HRC), which has funded nine research projects over the past seven years in which this 
data collection methodology has been used (Aporosa et al., 2021).  
 
The status of the faikava methodology has been commented on elsewhere by the author. 
 
The lengthy use of the faikava methodology in research, together with kava’s recognition as a safe, 
non-addictive substance that facilitates quality talanoa (Aporosa, 2019a) and its endorsement by the 
HRC due to its inclusion in stringently assessed and subsequently funded projects, has led to a 
recognised and authenticated Pacific-based research data collection mechanism. (Aporosa et al., 
2021, p. 83) 
 
The naturalistic kava-use environment used in the methodology is explained further in section 
3.6: Location of the kava session. 
 
3.1 Determining participant numbers 
Dr Ray Littler, a biostatistician at the University of Waikato, was consulted about the number of 
participants required for the results to achieve statistical significance. Dr Littler used power 
calculations (based on the overall cortical metric values obtained from the use of the Brain Gauge 
tool during the feasibility study) to determine the minimum number of participants required for 
the study to produce statistically significant results: n=15. However, it was considered that 
increasing the number of participants to n=20 would substantially increase the statistical 
significance to a 98 per cent probability level and allow for dropouts. These calculations are 
represented in Figure 3. 
 
 
Figure 3: Power calculations (using Power Curve 2-sample t-test) used to determine minimum participant numbers 
required to ensure the statistical significance of the data (Dr Ray Littler, 24 May 2018). 




3.2 Participant recruitment and eligibility 
Initial recruitment was for male participants over 18 years of age who held a full (unrestricted) 
driver’s license. Males were targeted, as historically they have been the dominant kava-consuming 
gender. Females are, however, increasingly drinking kava, which has led to the emergence of 
female-only groups attending faikava venues (Lolohea, 2021; Tecun et al., 2020). It is anticipated 
future testing will include both a female active and control cohort. 
 
Through this recruitment, 26 kava-using participants were identified, all of whom were 
recruited from faikava venues in Hamilton and Auckland. In the study, this group is referred to as 
the ‘active’ group. In addition, 25 non-kava drinking participants were recruited by word of mouth 
and through online advertisements and noticeboards at the University of Waikato. This group is 
referred to as the ‘control’ group.  
 
All recruits completed an eligibility screening form to ensure they were in good health, free of 
neurological or psychological conditions (for example, previous head injury, concussion or 
psychotic disorders), and were not taking any anxiolytic, antipsychotic or sleep medication. The 
form required recruits to answer a range of simple questions related to these matters by ticking 
either ‘yes’ or ‘no’.   
 
Recruits in the active group were also questioned about their kava use; allowing novice kava 
users to be identified and excluded, as the study required participants who regularly consumed 
kava at high volumes over multiple hours.  
 
Eligibility screening for the control group asked whether the recruits had ever consumed kava, 
and if so, how recently. For those who indicated they had previously used kava, that use had 
mostly occurred as part of a cultural experience at the University of Waikato or while on holiday 
in Fiji.  
 
The eligibility screening reduced the number of participants to n=20 in each group, complying 
with the 98 per cent statistical significance probability level identified from the power calculations.   
 
Participants were given an information sheet explaining the research aims, procedures, 
expected time commitment, and the requirement not to consume any alcohol in the 24 hours 
before testing, and no coffee, energy drinks or Coca-Cola in the 6 hours before testing. Control 
participants were also reminded that they must not consume any kava at all in the period prior to 
testing. Active participants were requested not to consume any kava in the 4 days prior to testing. 
This 4-day washout period is based on current understandings of kava elimination half-life, as 
explained in the section 2: Background (Aporosa, 2008). 




Just prior to the commencement of testing, one control participant was forced to withdraw 
due to an unexpected incident at home. Due to time limitations, he was unable to be replaced. 
 
3.3 Participant demographics 
The age and ethnic breakdown of the 39 participants who completed the testing is presented in 
Table 1.  
 
Participants were all males and included people of Pacific Island and other ethnicities, to reflect 
the increasing use of kava by non-Pacific people (Aporosa, 2015; Aporosa & Forde, 2019). The 
average age of the participants was 34.12 years (SD = 9.61); with the average age of those in the 
active group being 32.75 years (SD = 8.59) and in the control group 35.57 years (SD = 8.58).  
 
Table 1: Age and ethnicity of active and control participants 




AGE ETHNICITY AGE ETHNICITY 
1 34 Guatemalan 24 Tongan 
2 34 Tongan 32 Vietnamese 
3 31 Hawaiian 49 Māori 
4 41 NZ European 49 Māori 
5 27 NZ European 34 Vietnamese 
6 30  Fijian 31 Fijian 
7 51 Fijian 49 NZ European 
8 48 Fijian 50 Māori 
9 27 Tongan 21 Māori 
10 29 Tongan 36 NZ European 
11 31 Fijian 44 Māori 
12 36 Fijian 30 Samoan 
13 48 Fijian 49 Fijian 
14 30 Fijian 24 Fijian 
15 23 Tongan 25 NZ European 
16 28 Tongan 31 Māori 
17 22 Tongan 18 Māori 
18 37 American Withdrew 
19 27 Samoan 39 Māori 
20 22 Samoan 41 Māori 
 
Fijians represented the greatest number of active participants in the study (eight), with two in 
the control group. Tongans were the next largest active participant group, with five, and one 
control participant. All of the eight Māori participants were in the control group. Although this 
number of Māori control participants was similar to Experiment 1, that earlier investigation also 




had three active Māori participants (Aporosa et al., 2020). New Zealand European representation 
totaled five participants: three active and two control. Interestingly, the study also included one 
active participant of Guatemalan ancestry who has been drinking kava for many years and two 
Vietnamese control participants who accompanied an active participant.  
 
3.4 Briefing and preparing participants for the test 
The total participant group was split in two for the testing; with testing carried out on two separate 
occasions, and each occasion hosting 10 active and 10 control participants. This number allowed 
for appropriate management and observation of participants during the tests.  
 
On both test-days, research assistants transported the participants from their homes to a large 
meeting room adjacent to a computer lab at the University of Waikato, which would serve as the 
faikava venue during the test. 
 
Participants arrived at 6pm, allowing them time to be briefed on the study procedures, sign 
consent forms (including an explanation of their ethical rights as a research participant) and 
complete a short questionnaire. The questionnaire replicated some of the questions asked during 
the eligibly screening phase, to ensure participants had refrained from using kava for the 
designated period before the test, were still in good health, had not started taking new medicines, 
and had not consumed alcohol in the past 24 hours or caffeine, energy drinks or Coca-Cola in the 
past 6 hours.  
 
Participants were advised that if they had any questions at any point they were free to ask and 
an open and transparent answer would be given; and that should they wish to withdraw from the 
study, they were free to do so, and a taxi would be ordered to take them home. With the exception 
of the control participant who needed to leave for family reasons, no other participants withdrew 
from the study. 
 
After the consent forms were signed, participants attended a nearby lecture theater where 
they viewed a short video explaining the Brain Gauge test and were given a full explanation of the 
test procedures (as detailed in sections 3.7 to 3.9). Participants were advised that their kava 
intake, and any other liquid or food consumed during the test period, would be recorded by a 
research assistant, who would also note any unusual behavior among the participants, as the test 
proceeded. The participants were then given time to ask questions.  
 
Following this, the participants were taken to the computer lab to complete the first 
psychometric test session, using the Brain Gauge, to provide baseline data. Once baseline testing 




was complete, all participants returned to the faikava venue and were invited to sit on woven 
mats, where isevusevu was presented.  
 
iSevusevu is a Fijian-influenced cultural practice in which attendees are acknowledge and the 
purpose of the isevusevu explained. In this case, the participants were thanked for their time and 
participation (Aporosa, 2014a). All Pacific people have cultural practices similar to isevusevu, 
including Māori whose equivalent practice is known as pōwhiri and whakatau (Aporosa & Forde, 
2019). By conducting isevusevu as part of the faikava methodology, this complies with and 
upholds Pacific cultural expectations and obligations, as guided by a post-development Pasifika 
methodological framework (Aporosa, 2014; Aporosa et al., 2021).  
 
Over the following 6 hours, the participants drank kava (if they were members of the active 
group), engaged in talanoa, consumed chasers (see section 3.6) and occasionally left the room to 
use the toilet. The control participants did not consume kava at any point during the testing phase.   
 
3.5 Preparing the kava 
Dried powdered kava root and basal stump, originating in Fiji and sold under the Green Gold 
brand, was purchased from a reputable kava retailer in Hamilton, New Zealand. Green Gold kava 
powder is sold in sealed bags, as shown in Figure 4.  
 
 
Figure 4: Green Gold kava powder, used to mix the kava beverage used during testing  
 
A sufficient quantity of kava was sourced for both test-day sessions to aid standardisation. Kava 
powder, retained for the second testing session, was compressed into heavy-duty plastic bags and 
stored in an airtight container in a dry dark cupboard at approximately 18°C, to maintain its 
freshness (AECOM-Kalang, 2017).   
 
 




Approximately 1 hour before each test session, the author mixed 36 litres (9.51 gallons) of kava 
for consumption during the test. The author has over 20 years’ kava-use experience, and the 
mixing procedure used a standard recipe to produce a kava beverage with a similar concentration 
to that usually consumed in faikava environments in New Zealand. The recipe used was also 
chosen for its ease of duplication.   
 
The prepared kava was served to the participants in the active group from a kumete, in bilo/ipu 
(cups made from coconut shells), at 100ml (equivalent to 0.2 pints) portions (see Figure 5 and 
Figure 6). Portions were served at the rate of six serves per hour, throughout the 6-hour test 
session; meaning that each active participant consumed 3.6 litres of kava during the session.   
 
 
Figure 5: Kava being poured into the kumete for serving to study participants. (Photographer: Todd M. Henry, 2019) 
 
Figure 6: Kava being served, in bilo/ipu from a kumete, during the test session (Photographer: Todd M. Henry, 
2019) 
 
3.6 Location and set up of the kava session 
The room where the kava was consumed during the study was set up to reflect a faikava space, 
or a typical kava session venue. To replicate that naturalistic environment, woven mats were 
placed on the floor, which the participants sat on cross-legged while consuming the kava (see 
Figure 7).  
 





Figure 7: The faikava environment used during the study (Photographer: Author, 2019) 
 
The author ensured that all cultural kava consumption protocols were adhered to throughout 
the session (Aporosa, 2014a). This adherence to protocol, together with the naturalistic setting, 
encapsulated the faikava methodology, as used in previous kava cognition studies. 
All of the participants were invited to partake of snack foods, at their leisure, during the test 
period. These foods were typical kava ‘chasers’, or food items consumed during a regular kava 
session, and included salted potato chips and peanuts, apples, pears, bananas and sweets (see 
Figure 7). The sweets provided were sugar-free to limit any potential cognitive stimulant effect; 
this was done purely as a precautionary measure, contrary to research that argues “that the idea 
of a positive CHO–mood relationship is unsubstantiated” (Mantantzis et al., 2019).  
  
The drinks offered (in addition to kava) were water and sports rehydration drinks, as 
participants had been asked to avoid any Coco-Cola, energy drinks or caffeine. Participants were 
free to move about the venue and leave it to use the toilet throughout the testing session, 
although members of the active group were advised to be in the room at kava serving times, and 
all participants were required to be available for testing in the computer lab.   
 
Although the study adhered to some strict conditions, flexibility around the consumption of 
chasers, along with the freedom to move about were allowed, so as to create a naturalistic kava 
consumption setting and to comply with the structure of the faikava methodology (Aporosa et al., 
2021).  
 
3.7 Psychometric tests used in the cognitive assessment 
The cognitive assessment of participants during the study was conducted using the Brain Gauge 
testing tool (www.corticalmetrics.com). Brain Gauge is an innovative tool that measures slight 




changes in strategic, tactical and operational cognitive faculties, including fine motor skills and 
fatigue, to assess neurological functioning (King et al., 2018).  
 
Shaped like a typical computer mouse, the Brain Gauge device has two probes (each 5mm in 
diameter) on which the participant rests the index and middle finger of their non-dominant hand. 
The participant also controls a standard computer mouse using the dominant hand. This standard 
computer mouse is used to register responses delivered by the Brain Gauge probes. The Brain 
Gauge tool is paired with a Brain Gauge application, which delivers the test battery via a computer 
screen. This set-up is shown in Figure 8. 
 
 
Figure 8: “The ‘Brain Gauge’ (A) two-digit vibro-tactile stimulation handheld device and (B) example of visual cueing 
test screen” (King et al., 2018, p. 3). 
 
During the test, the Brain Gauge probes deliver a vibratory stimulus (with a flutter range of 25 
to 50 Hz) to the participant’s non-dominant index and middle fingers, and the application presents 
the participant with a range of nine tasks related to this stimulus. For example, the participant 
may be asked to click the mouse key (using the dominant hand) as quickly as possible when they 
feel a vibratory stimulus delivered through the probes, in order to record the reaction time 
between when the stimulus is delivered and the participant’s response. 
 
The nine tasks delivered by the application measure2: 
● Speed – reaction time and reaction time variability, with fatigue as a variable 
● Accuracy – sequential amplitude discrimination and simultaneous amplitude 
discrimination 
● Temporal Order Judgement and Connectivity – to measure sequencing and how well 
brain cells are communicating with each other 
● Timing Perception – duration discrimination 
● Plasticity – to measure how well the brain is integrating, processing and adapting to 
information from the external environment  
 
2 For ease of reference, the six attributes measured during the testing will be capitalised throughout the report.   




● Focus – associated with motivation, attention span, determining similarities and 
differences between objects or events, and the ability to predict future consequences 
(King et al., 2018; Tommerdahl, 2017). 
 
Brain Gauge also calculates an overall composite score (cortical metric), together with 
individual task scores, which are presented alongside normative scores (Cortical Metrics, 2017;  
see also Figure 9). These performance measures can be applied to the strategic, tactical and 
operational cognitive aspects needed to understand driver capacity and performance (Barkley & 
Cox, 2007).  
Brain Gauge has test–retest functionality (meaning results are not compromised with repeated 
use), and has been used in more than 60 major studies measuring traumatic brain injury, drug use 
and autism, resulting in 45 peer-reviewed publications. In addition, Brain Gauge is increasingly 
being used (in the United States and, more recently, New Zealand) as a field-side neurosensory 
measure to assess concussion in professional sport (chiefly American football and rugby union). 
 
For this study, testing was completed in a computer lab adjacent to the faikava venue, where 
each Brain Gauge device, together with a standard computer mouse, was connected to a Dell 
Optiplex (9020) desktop computer running the Brain Gauge application. Participants were 
instructed to place their non-dominant hand on the Brain Gauge mouse, in such a way that their 
index and middle fingers were in contact with the probes, and their dominant hand on the 
standard computer mouse. If participants pressed too hard, the Brain Gauge application would 
instruct them to loosen their grip. 
 
Participants were requested to read the test instructions on the computer monitor carefully 
and to focus, while at the same time staying relaxed and answering each question to the best of 
their ability. The Brain Gauge application presented participants with a brief demonstration of 
what vibrations would feel like on their fingers. It then led the participants through the test 
battery, with each test taking between 1 and 3 minutes. The participants had to complete three 
practice trials at the beginning of most tests and were required to answer all three trials correctly 
before they could progress. Feedback was given on the practice trials, but not task trials. The total 
test battery took between 10 and 20 minutes to complete. 
 
Each participant was allocated to one of several research assistants who monitored their 
progress and addressed any issues during their use of the Brain Gauge tool. Once participants had 
completed the test battery, they were redirected to the Brain Gauge home page. The research 
assistants then directed them back to the faikava venue. Participants were not made aware of 
their scores or performance at any time during the testing. 




3.8 Testing intervals 
The study’s 6-hour duration was selected to represent the period of a typical traditional kava 
session (Aporosa & Tomlinson, 2014), and was consistent with the two earlier kava-cognition 
studies undertaken by the author (Aporosa, 2017b; 2020; Aporosa et al., 2020). 
 
Testing with the Brain Gauge tool occurred at three points during the study: 
● T1: baseline prior to any kava consumption 
● T2: halfway through the kava session (when participants had been drinking for 3 hours) 
● T3: when the kava session had ended, 6 hours after the consumption of the first bilo of 
kava. 
 
The participants were given 5-minute warnings before each test session. Brain Gauge baseline 
testing (T1) commenced at 6.30pm, and as explained earlier, was followed by isevusevu. The final 
Brain Gauge testing (T3) was undertaken following the sixth hour of kava consumption at 
12.30am. 
   
On returned to the faikava space, after the final testing, the participants were acknowledged 
with tatau. Tatau is similar to isevusevu, and in this case thanked participants for their time and 
participation. It also complies with Pacific cultural expectations and obligations, and the post-
development methodological framework and faikava methodology used in the study (Aporosa, 
2014a; Aporosa et al., 2021).  
 
The tatau provided an opportunity for some of the control participants to consume kava for 
the first time, and was followed by a substantial meal, and presentation of a $100 gift voucher to 
thank each of the participants for their time. All participants were provided with a ride home.  The 
test session took approximately 7.5 hours to complete. 
 
3.9 Analysis of the test data 
Brain Gauge test results are presented in both illustrative and numerical format, with the latter 
easily exported to a variety of software options for data analysis.  
 
Figure 9 shows a typical data output in illustrative form, as produced by the Brain Gauge 
application. The figure was produced following the feasibility study, and shows the test results for 
participant AA at baseline (T1), the midpoint at 3 hours (T2) and the completion of kava drinking 
at 6 hours (T3) (Aporosa et al., 2021).  
 
Although this mode of illustration is extremely valuable for interpreting the data of individuals, 
it is less clear for presenting group data.  





Figure 9: Brain Gauge output data: at baseline (T1); the 3-hour midpoint (T2); and at the conclusion of kava 
consumption at 6 hours (T3) for participant AA (Aporosa et al., 2021) 
 
In the study, instead of generating Brain Gauge illustrations, the numerical data was exported 
and analysed using Student’s t-test (Normal), a nonparametric statistical test that comes in two 
versions: the Wilcoxon signed-rank test and the Mann-Whitney U test (rank sum); together with 
Bayesian inference techniques.   
 
Student’s t-test and non-parametric analysis compares and measures the significance of 
differences between paired groups: in this study, that was the difference between the active and 
control groups. Bayesian analysis produces a ‘Bayes factor’, which is used for comparative 
analysis. A Bayes factor represents a ratio of the likelihood of a specified hypothesis (e.g. the effect 
of a treatment) compared to a second hypothesis (e.g. the treatment having no effect). 
 
 
4 Results and discussion 
4.1 Kava analysis  
Several weeks after completion of testing, the author took a 200gm (7.05 ounce) sample of the 
Green Gold kava powder used in the testing to the New Zealand Institute of Environmental Science 




and Research in Wellington for analysis. While there, the author also mixed a sample of kava using 
the same recipe as used for testing.  
Both the powdered Green Gold kava and the mixed sample were tested by an institute 
scientist. The kava was found to contain no adulterants, with a strength rating of 5 per cent total 
kavalactones by dry weight, a chemotype of 462531, and a mean kavalactone content of 115mg 
per 100ml of kava beverage. 
 
4.2 Kavalactone ingestion volumes 
All 20 of the active participants consumed the maximum of 3.6 litres (7.6 pints) of kava over the 
6-hour test period, drinking the full 100ml of kava at each serving.   
 
With the analysis showing the presence of 115mg of kavalactones per 100ml of kava beverage, 
this equates to each active participant having consumed 1,840mg of kavalactones by the time of 
the T2 Brain Gauge test after 3 hours of kava drinking, and 3,680mg after 6 hours of kava 
consumption, just prior to the final test (T3).  
 
This level of consumption is almost 15 times greater than the pharmacologically recommended 
dose.   
 
4.3  Psychometric test data 
As explained in Section 3.7, the Brain Gauge test battery comprises nine tasks which measure six 
cognitive attributes or domains: Speed (with Fatigue as a variable), Accuracy, Temporal Order 
Judgement, Timing Perception, Plasticity and Focus.  
 
Additionally, in section 3.10, it was explained that while the Brain Gauge application presents 
the test data of individuals in a user-friendly illustrative format, as shown in Figure 9, this is not 
the case with group data. Therefore, the data analysis in this study will, in the first instance, be 
presented in Tables 2, 3 and 4. These will be followed by specific points of discussion, accompanied 
by simple box-plots (and in one case violin-plots).  
 
Within the Tables, p-values for t-test and nonparametric statistical test data meeting statistical 
significance (≤ 0.05), and Bayesian analysis data greater than a cutoff of 2.5, are either highlighted 
in bold text or underlined. This will aid discussion in the following sections. 
 
Tables 2.1, 3.1 and 4.1 present within-cohort data (comparing control group data with control 
group data, and active kava using group data with active kava using group data) at the three test 
points (T1, T2 and T3, as explained in section 3.8). Although some of that within-cohort data is 
statistically significant (≤ 0.05) (for instance, the control group shows a marked regression in 




Plasticity, or how well the “brain is integrating, processing, and adapting to information from [the] 
external environment” (King, Hume, & Tommerdahl, 2018, p. 4) between their T1 baseline and T2 
midpoint third-hour test [W=0.002838; t=0.001382; BF=27.93537], whereas no change is evident 
among the active participants for the same period) only one data set (active group Focus) will be 
discussed here.  
 
Concerning the within-active-cohort Focus data, Table 2.1, 3.1 and 4.1 show a statistically 
significant level of impairment to the Focus of the active participants at T2 (or following 3 hours 
of kava use): [W=0.03315; t=0.02225; BF=2.651865].  However, at T3, and following 6 hours of 
kava drinking, the Focus of the active participants shows a (non-statistically significant) level of 
improvement: [W=0.08003; t=0.0599; BF=0.1243]. That change in a positive direction (as opposed 
to a regression) can be seen in Figure 10, which is a simple box-plot showing the results of the 
group statistics t-test analysis.  
 
Together with an observational comment in section 4.4, this positive change in Focus will be 
discussed in section 4.5 in relation to driving.  
 
Table 2: Non-parametric analysis of Brain Gauge output data 
 
2.1 Group-wise (analysed with the Wilcoxon signed-rank test [W]) 







Control-T1 v Control-T2 













Active-T1 v Active-T2 














2.2 Test-wise (analysed using the Mann-Whitney U test (rank sum) [MW]) 







Control-T1 v Active-T1 
Control-T2 v Active-T2 





















Of greater interest are Tables 2.2, 3.2 and 4.2, which present the between-cohort data 
(comparing data from the control group and the active kava using group) at the three test points 
(T1, T2 and T3).  




Table 3: t-test analysis of Brain Gauge output data 
 
3.1 Group-wise [t] 







Control-T1 v Control-T2 













Active-T1 v Active-T2 














3.2 Test-wise [t] 







Control-T1 v Active-T1 
Control-T2 v Active-T2 





















Table 4: Bayesian analysis of Brain Gauge output data represented as Bayes Factor [BF] 
 
4.1 Group-wise [BF] 







Control-T1 v Control-T2 













Active-T1 v Active-T2 














4.2 Test-wise [BF] 







Control-T1 v Active-T1 
Control-T2 v Active-T2 



























Figure 10: Simple box-plot showing the Focus data 
 




At odds with the hypothesis (as presented in section 2.4), the results show no statistically 
significant level of impairment to the following five cognitive attributes or domains for the active 
participants (when compared with the control participants) over the course of the 6-hour kava-
use session. 
● Focus – or how well the “brain is able to concentrate on the task at hand” which is 
“associated with motivation, attention span, determining similarities and differences 
between objects or events, and the ability to predict future consequences” (Pawluk, 2018c).  
● Accuracy – or how well the “brain is able to differentiate between similar sensations or 
stimuli” which is “responsible for integrating sensations that are detected by different parts 
of the body” (Pawluk, 2018a). A simple box-plot showing the Accuracy data is presented in 
Appendix A. 
● Timing Perception – or how well the “brain is able to keep track of time” which is linked to 
“motor learning, balance and coordination, and timing accuracy” (Pawluk, 2018f). A simple 
box-plot showing the Timing Perception data is presented in Appendix B.  
● Plasticity – or how well the “brain is able to react and adapt to changes in [the test subjects] 
surroundings”, allowing response adjustments to new situations and environmental change 
(Pawluk, 2018d). A simple box-plot showing the Plasticity data is presented in Appendix C. 
● Fatigue – or how the “brain tires during a mentally demanding task”, which has an impact 
on reaction time (Pawluk, 2018b). A simple box-plot showing the Fatigue data is presented 
in Appendix D. 
 
Although the data described above shows no statistically significant changes for five of the 
domains measured by the Brain Gauge, there are nevertheless two points of interest.  
 
The first point of interest relates to Timing Perception. Tables 2.2, 3.2 and 4.2 (and Appendix 
B) show no statistically significant change in Timing Perception for the active group when 
compared with the control group over the 6-hour period ([MW=0.4986; t=0.4068; 
BF=0.4108801]). Within the Brain Gauge test definitions, Timing Perception includes “balance and 
coordination”. Therefore, the data suggests kava use over 6-hours has no negative impact on the 
drinker’s ability to maintain body position control during the execution of a task. This finding 
contradicts a recent master’s degree study in which participants (n=6), who also attended a 6-
hour kava-use session employing the faikava methodology, had their balance and coordination 
assessed using a force-plate and y-balance measure (Aughton, 2020). Preliminary results from a 
reanalysis of the data suggests participant balance is statistically significantly compromised at T3. 
That study will be published in coming months. 
     
The second point, which is of greatest interest, is the Temporal Order Judgement test scores. 
Data in Tables 2.2, 3.2 and 4.2, which compares the Temporal Order Judgement scores of the 




active kava users (with those of the control group), shows a significant level of regression in 
participants’ Temporal Order Judgement at T3: [MW=0.0119; t=0.007301; BF=6.193058]. Figure 
11 presents a simple box-plot of the results of this data. Figure 12 shows the same data presented 
as a violin-plot, to provide alternative illustration.  
 
Temporal Order Judgement includes sequencing and is associated with “how well [the] brain 
is able to keep track of the order of events” (Pawluk, 2018e). King, Hume and Tommerdahl (2018) 
add that Temporal Order Judgement, as assessed by the Brain Gauge, is a “metric associated with 
the ‘when’ pathway (frontal-striatal)” (p. 4). With “frontal-striatal pathways control[ing] many of 
the brain's executive functions, including decision making, behavioral control, and information 
processing” (Pawluk, 2018e), this is argued to have implications for safe driving, a theme that will 
be discussed in section 4.5.  
 
This finding of regression in participant’s Temporal Order Judgement supports, to some extent, 
the study hypothesis (as presented in Section 2.4), with the acknowledged limitation that kava 
appears to impact only one of the six domains measured by the Brain Gauge. Due to the large 
knowledge gaps concerning kava neuroscience and neuro-psychopharmacology, which is 
exacerbated when associated with naturalistic kava use (Aporosa et al., 2021; Bwarenaba et al., 
2017), reasoning or speculation will not be offered concerning the apparent lack of impact on the 
other five domains.  
 
4.4 Observations 
Following the approach adopted in Experiment 1, the author and research assistants discussed 
any observations they made during the test period regarding changes in the participants’ 
behavior. 
 
As with Experiment 1, subtle changes were noted in many of the active participants, with these 
changes often becoming more noticeable after 4 hours of kava use (Aporosa et al., 2020). Changes 
noted included slowed psychomotor response, a somnolent-like state, slightly altered word 
pronunciation and a slowed speech rate.  
 
These observations align with reports from both New Zealand and Pacific-based police, who 
state that kava drink-drivers observed during road-side stops typically exhibit decelerated body 
movement and slurred or slowed speech (Berry et al., 2019; Galuvoa, 2018; Kalura, 2018; Mishra, 









Figure 11: Simple box-plot showing the results of the Temporal Order Judgement data 





Figure 12: Violin-plot showing the results of the Temporal Order Judgement data 




Observationally, there is an additional point of interest. At T1 baseline testing, the control 
participants generally appeared a lot more focused on the computer screen than the average 
active participant. For instance, the control participants appeared to lean further forward in their 
chair, allowing closer proximity to the computer screen and suggesting an increase in 
concentration when undertaking the Brain Gauge task. At T2, the control participants appeared 
slightly less intent and focused, adopting a slightly more relaxed posture, when compared with 
T1. At T3, the control participants were vastly more relaxed, giving the appearance they either 
‘knew’ the test and were comfortable with it and their surroundings, or they were tired.  
 
However, the possibility of tiredness must be treated with caution; particularly as the data does 
not support this idea. For instance, at T2, the data shows the control participants as having a 
statistically significant level of Fatigue: [W=0.02874; t=0.0267; BF=2.327754], whereas at T3 the 
data shows an improvement in Fatigue: [W=0.07028; t=0.05641; BF=1.288536]. 
 
Conversely, the active participants appeared more relaxed than the control group at T1, 
although at T2 and T3 there appeared to be an incremental increase in how they sat in their chairs 
and focused and interacted with the Brain Gauge task. For instance, at T1, the active participants 
appeared relaxed and ‘laid-back’ in their seated position, engaging with the Brain Gauge task in a 
more relaxed manner than their control counterparts. However, at T2, they appeared to lean 
forward more in their chairs, moving slightly closer toward the computer screen and suggesting a 
greater level of concentration on the task when compared with T1. That increased level of 
perceived vigilance though did not appear to be carried back into the faikava environment, 
following the T2 test. The active participants appeared to relax back into the kava-use session 
after the test, exhibiting early stages of somnolence and a slight slowing of speech rate, as already 
described. 
 
At T3, most of the active participants appeared even more focused on the Brain Gauge task 
than they did at T2. This included moving further forward toward the computer screen and bodily, 
assuming a subtle, yet greater, degree of postural rigidity (with less body movement) than at T2. 
On return to the faikava space following the final T3 test, the active participants appeared to 
return to their pre-T3 test relaxed state, with some stating it was ‘good to be able to now relax 
and enjoy the kava’, suggesting testing had been demanding.  
 
Admittedly these comments are based on speculation linked to observation. However, this 
change in demeanor by the active participants from T1 to T3 – from a relaxed state to a more 
focused and intent presence – also appears to be reflected in the active participant Focus scores 
and the shift from a statistically significant level of regressed Focus at T2 [W=0.03315; t=0.02225; 
BF=2.651865] to an improved level of Focus at T3 [W=0.08003; t=0.0599; BF=0.1243].  




This improved level of Focus is also reflected in the Fatigue data, showing a non-statistically 
significant level of Fatigue improvement from T2 [W=0.03636; t=0.03301; BF=0.3611313] to T3 
[W=0.9687; t=0.8949; BF=0.2342181].  
 
4.5 Focus, Temporal Order Judgement and driver safety 
The data shows an improvement in the Focus (and Fatigue) of the active participants between T2 
and T3, despite the fact that the participants had been at the test venue for over 6 hours and the 
final T3 test was conducted at 12.30am. With kava’s dominant effects reported as soporific, 
anxiolytic and relaxant (Cairney, Maruff, & Clough, 2002; Duffield & Jamieson, 1988; Pittler & 
Ernst, 2003; Singh & Singh, 2002), it would be expected that the data would show a regression in 
both the Focus and Fatigue scores as the testing progressed. Due to large gaps in kava 
neurophysiological, metabolism, drug half-life and neuro-psychopharmacology understanding, it 
is not currently possible to provide a physiological reasoning for this Focus and Fatigue score 
improvement on the part of the active participants.  
 
Taken at face-value, what the results currently suggest is that kava may have a small positive 
effect on Focus; that following 6 hours of traditionally influenced kava use, this potentially 
improves how well the “brain is able to concentrate on the task at hand” (King et al., 2018; 
Tommerdahl, 2017), as well as enhancing “motivation, attention span … and the ability to predict 
future consequences” (Pawluk, 2018c). This in turn would slightly enhance a driver’s alertness and 
therefore improve driving safety. However, it is argued that that statement should be treated with 
caution, as the data shows a very different effect on Temporal Order Judgement. 
 
At T3, at a time when each active participant had consumed 3,680mg of kavalactones, data 
shows a significant level of impairment to participants’ Temporal Order Judgement [MW=0.0119; 
t=0.007301; BF=6.193058]. As a reminder, the Brain Gauge measure of Temporal Order 
Judgement is associated with the “integrity of the frontal-striatal cortex … the frontal-striatal 
pathways control[ing] many of the brain's executive functions, including decision making, 
behavioral control, and information processing” (Pawluk, 2018e).  
 
In their comprehensive literature review evaluating measures of executive function, 
Asimakopulos and colleagues (2012) report that executive function plays a vital role in safe driving. 
To assist their claim, they define the operational components of executive function as, 
 
Decision-making / judgment - The assessment and ‘ordering of various competing actions and 
goals’. 
Impulse control / inhibition - ‘The ability to suppress automatic actions that are inappropriate in a 
given context that interfere with a certain behaviour’. 




Self-awareness / insight - The ‘ability to critically appraise our own actions and the actions of those 
around us’. 
Cognitive flexibility - ‘The ability to shift between response sets, learn from mistakes, devise 
alternative strategies, divide attention, and process multiple sources of information 
concurrently’. 
Planning - ‘The ability to envision both the ideas contained in a strategy and the steps involved in 
a tactical approach to realising the strategy’. 
Working memory - Executive process responsible for the temporary storage and manipulation of 
information in both simple (e.g. recalling a series of digits, such as a phone number) and 
complex cognitive tasks (e.g. coordinating two tasks simultaneously). (p.403) 
 
Anstey and colleagues (2005) add that “executive function is necessary for integrating 
information and planning a response” (p. 46). They illustrate the importance of the connection 
between information integration and response planning on the one hand, and safe driving on the 
other, by stating that as we age our faculties of executive function decrease. They then 
hypothesise that the over-representation of elderly drivers involved in motor vehicle accidents at 
intersections (noted to be driving situations that involve complexity: “(i.e., the planning and 
decision-making part of the driving task)”) correlates with that decline (p. 46).   
 
What is confusing in the current study is that although the data shows an improvement in Focus 
scores for the active kava drinking participants from the T2 to T3 tests, it also shows a significant 
decline in Temporal Order Judgement, and therefore a negative impact on executive function, 
over the same period. Put another way, the data suggests that while the active kava drinking 
participants showed improvements in concentration “motivation, attention span … and the ability 
to predict future consequences” (Pawluk, 2018c) from T2 to T3, they equally showed a significant 
decline in their ability to coordinate complex tasks and in “planning and decision-making” (Anstey 
et al., 2005, p. 46).  
 
This confound was discussed with several psychopharmacology experts who, although unable 
to explain the anomaly, recognised that understanding of the effect of kava on cognition when 
consumed at traditionally influenced volumes (as opposed to modified pill-style kava) is still new 
and evolving.  
 
However, what also needs to be recognised is that “[Executive function] is a complex construct 
to both understand and assess” (Asimakopulos et al., 2012, p. 423), suggesting that the confound 
cannot be solely explained by reference to the kava-science knowledge gap. Where this anomaly 
may have application is in clarifying comparisons between kava and benzodiazepine, particularly 
as kava is often compared to this prescription anxiolytic. For instance, when benzodiazepine dose 
is markedly increased, effects commonly include interference with reasoning or judgement, over-
sedation, loss of coordination, marked euphoria, excitability, aggression and loss of consciousness 




(Liebrenz et al., 2016). This does not occur when kava is consumed at high volumes. Put simply, 
kava and benzodiazepine have similar effects at low dose. However, at high dose they are very 
different, with the consumption of high kava volumes not leading to a marked loss of thinking 
clarity, control or consciousness.  
 
It is valuable at this point to further consider kava’s effects in comparison to other drug 
substances, particularly as the effect of kava has been compared with alcohol intoxication – 
leading to the commonly used term kava intoxication – as well as laudanum, cannabis, opiates 
(narcotics), and hallucinogens (Aporosa, 2019a). In an earlier section, it was stated that unlike 
alcohol and most other recreational drugs, kava drink does not cause marked euphoria or 
hallucination, instead inducing relaxed feelings and clear-headedness (Aporosa, 2011; 2019a; 
Carlini, 2003). Much of that understanding is based on ethnographic commentary. These current 
findings add quantitative support to that qualitative data, demonstrating that kava’s effects are 
not only different to high-dose benzodiazepine use (as described above), but also vastly different 
to many of the drug substances kava is compared with.  
 
For instance, in their chapter on the ‘Influence of drugs on cognitive functions’, Juárez-Portilla 
and colleagues (2018) explain how a selection of depressant and stimulant drugs impact cognitive 
faculties. Stimulant drugs, which include methamphetamine and cocaine, are not discussed here 
as kava has not (to the author’s knowledge) been compared with these drugs. Instead, this 
discussion focuses solely on two key depressant drugs: alcohol and cannabis.  
 
Juárez-Portilla et al. note that alcohol has a “biphasic effect on brain activity, causing excitation 
and euphoria … confusion, loss of awareness and selective attention begin to occur, significantly 
diminishing the execution of working memory and its long-term consolidation.” (p. 63) Cannabis 
is also noted to induce mild euphoria leading to impaired basic motor coordination, disrupted 
planning, organisation and problem-solving ability, and interference with decision making and 
emotional and behavioral control. The authors point out, though, that the severity of any 
impairment depends upon cannabis cultivar strain, use quantity and frequency, with habitual use 
playing “an important role in the diminution of gray mater”. (p. 64)  
 
As the findings of this study show, while kava has a significant impact on Temporal Order 
Judgement, no interference occurs to most of the cognitive faculties disrupted by alcohol and 
cannabis use. This also shows that kava effect cannot be described as hallucinogenic; with drugs 
that do fall under this category typically causing hallucinations and anomalies in perception 
together with considerable change in subjective thought, consciousness and emotion (Goldberg 
& Dillon, 2005). Additionally, this study shows that kava’s effects cannot be described as narcotic, 




also a common effect descriptor applied to kava3. As the U.S. Drug Enforcement Administration 
(2020) explains, “the term ‘narcotic’ comes from the Greek word for ‘stupor’” and is linked to high 
opiate use (p.1), an effect clearly lacking in high-volume kava use.  
 
Finally, the present discussion demonstrates that the common term used to capture kava’s 
effects following high-volume use, ‘kava intoxication’, is misleading and incorrect. This is 
particularly the case when ‘intoxication’ is commonly defined as “having physical or mental 
control markedly diminished” (Merriam-Webster online dictionary).    
 
By drawing on the study findings and literature that explains how selected drugs impact 
cognitive faculties, this study clearly shows that kava, when consumed in naturalistic settings over 
many hours, has unique but subtle effects. These are vastly less impactful on cognitive faculties, 
and very different to the effects of alcohol, cannabis, hallucinogens and narcotics. However, it 
must by noted that although this present discussion explores differences in effect between 
differing substances, it is not suggesting that kava has no impact on driver safety.     
 
In the early stages of this report, it was explained that naturalistic traditionally influenced kava 
consumption typically occurs in communal environments, over many hours, with users routinely 
drinking more than 20 times the pharmaceutically recommended daily dose; and an estimated 70 
per cent of those users then driving home, some long distance and inter-city. It was also explained 
that police are stopping what they suspect are increasing numbers of kava-impaired drivers, but 
lack suitable evidential-standard measures to assess these drivers’ competency (for example, 
blood or breath-screening tests, which “research has shown … is the most effective way to deter 
drink-driving” (Smith, 2013, p. 24)).  
 
This study indicates that high traditionally influenced volumes of kava consumption can 
significantly impair decision making, behavioral control and information processing linked 
specifically to Temporal Order Judgement as defined in the Brain Gauge descriptor. This raises the 
issue and challenge of how to modify driver behavior when it comes to combining kava 
consumption and driving. This challenge will now be discussed.  
 
4.6 Encouraging driver behavioral change 
In relation to drug-impaired driving, Watson and Mann (2018) explain that, unlike alcohol drink-
driving, research shows, 
  
 
3 A search of the authors Endnote library lists 57 books, published papers and news items describing kava as a 
‘narcotic’. 




relatively high degrees of willingness or intent to engage in [drug impaired driving … as] many users 
do not view their driving as impaired… In some contexts, [drug impaired driving], therefore, appears 
to be a fairly ‘normalised’ behaviour among people who use drugs, particularly if it is common among 
one’s peer group. (p. 106) 
 
With 70 per cent of kava users reportedly driving home following kava use, and some of that 
driving being long distance (Auckland to Hamilton and vice-versa being common, for instance), 
this would suggest driving following kava use is also a fairly normalised behavior.  
 
Watson and Mann (2018) suggest a harm-reduction approach to address drug-impaired 
driving. The central theme of harm-reduction theory acknowledges that societies will never be 
drug free, yet “recognizes that the [substance] user has the ability to act responsibly and to make 
choices to stop or modify risky behavior” (Loue, 2003, p. 74). A key aspect of modifying risky driver 
behavior, including drug-impaired driving, is education that considers the cultural and social 
norms of the target audience (Lewis et al., 2019; Negi, 2020, p. 9). In their paper focused on 
designing and evaluating road safety messaging and campaigns, Lewis and colleagues (2019) 
explain the “transforming approach”, a harm reduction measure that “aims to influence 
community-wide attitudes, values, and norms relating to risky and/or illegal road user behaviors 
… [which] is intended to motivate people to align their behavior with perceived community 
expectations, values, and norms.” (p. 299) 
 
Across the Pacific, community expectations, values and norms are associated with cultural 
respect-based ideals linked to what is inferred as ‘chiefly behaviours’. These ideals are 
encapsulated in (although are not limited to) rispeck in the Bislama-speaking nations of the 
Western Pacific (Papua New Guinea, the Solomon islands and Vanuatu); vakaturaga in Fiji; 
fakaʻapaʻapa and anga fakaTonga in Tonga; tautua fatama’ali and fa’aaloalo in Samoa; kauraro 
Rarotonga in Te Au Maohi (or the greater Rarotonga island group); ke’ano pono in Hawai’i; and 
tikanga in Aotearoa New Zealand (Aporosa et al., 2021, p. 76; Hemi et al, 2021, p.30).  
 
Drawing on these Pacific-wide ideals, and with the aim of using respect (together with 
education, harm reduction and a transforming approach) to reach readers and reduce risky driving 
following lengthy kava use, a three-fold A4 (DL size) user-friendly brochure was produced by the 
author (see Figure 13). The brochure included a simple summary of police concerns about the 
effects of kava on safe driving; together with an explanation of the research and its findings, in 
particular kava’s impacts on Temporal Order Judgement (explained, for simplicity’s sake, in the 
brochure as slowed thinking and decision making). This information was combined with a 
challenge to kava-using drivers to reconsider whether they should drive after consuming kava, 
and if they choose to do so, whether this would align with their Pacific values of respect for other 
road users.  






























Figure 13: Cover and inside of English language kava drink-driving brochure 
 




To ensure the greatest possible reach and comprehension for the brochure’s message, it was 
translated into (standard) Bislama, Fijian, Tongan and Samoan (see Appendices E to H, 
respectively). This arguably provided language accessibility for the dominant kava-using 
nationalities. 
 
4.6.1 Trialing and evaluating the brochure and its kava drink-driving message 
Before distribution, the brochures were trialed and evaluated in several kalapu (kava-use venues) 
in Auckland, Hamilton and Canberra, Australia. COVID-19 travel restrictions prevented travel to, 
and testing of the brochures in the Pacific islands, as had been originally planned. 
 
In total, 62 people (male and female, representing a wide range of Pacific nationalities, 
together with some non-Pacific participants) took part in the evaluation. Initially, the brochures 
(in all five languages) were simply placed on the floor at the kalapu, unaccompanied by any 
commentary, to assess interest. At all kalapu, the people nearest the brochures immediately 
picked them up, with some drawing the attention of others present who then asked for a 
brochure.  At the Canberra kalapu, a male Tongan in his 30s was asked why he had picked up the 
brochure so quickly. He replied, “The picture [indicating the cover of the brochure], it’s about 
kava. I want to know.”  
 
During this initial period, attendees showed enthusiastic interest, with some asking for a 
brochure in their own language when they became aware this was available. There appeared a 
great deal of interest in the translated versions of the brochure, demonstrated in talanoa 
(discussion) about word comparisons across the various languages.  
 
The simple placement of the brochures on the floor at kalapu (without commentary) also led 
to unprompted talanoa about kava’s effects on cognition. This talanoa related to the brochure’s 
statement that, “Studies have shown that drinking kava can slow thinking and decision-making. 
This, in turn, affects how safely people drive.”  
 
Reading this prompted several people to describe their experience of driving following kava 
use.  For instance, a Fijian male in his 40s explained how he had to stop and sleep while driving 
from South Auckland to Hamilton in the early hours of the morning after drinking kava. He 
asserted that his driving was fine, and that he had only stopped due to tiredness. Conversely, 
another male, also Fijian and in his 40s, commented that, “One time, I was so dope [a colloquialism 
for the effects of high kava use] I drove over the Dinsdale roundabout”; prompting a laugh from 
many in attendance.  
 




At a different venue, a Fijian woman in her late 30s, whose husband was also present at the 
faikava, recalled a late-night trip home with her husband, who was driving, after drinking kava. 
She explained that her two children where in the back of the vehicle asleep, and that as they drove 
into a small rural town, she noticed the vehicle was slowly moving to the right and into the 
oncoming lane. She stated that if she had not been awake, and had it not been for the streetlights, 
which enabled her to see that her husband’s eyes were closed, or had there been an oncoming 
car, it was likely they would have died. The husband responded that it wasn’t the kava that had 
cause him to nod-off, but, “we got called out and I was working [the night before]. It was family, 
so we had to go up”; meaning that following an overnight work shift, he drove to another city for 
a family commitment, which involved kava use. The woman followed with, “Yes, he was tied. He 
only drinks [meaning ‘drank’] a little bit [of kava]”. 
 
At a separate venue, and after a participant asked the author for more information on what 
was meant by “slow thinking and decision-making”, at which Temporal Order Judgement was 
explained, another participant (a Tongan male in his early 30s) explained that when driving 
following kava use, and particularly when approaching intersections, he went through (what was 
described as) a ritual: double-checking the colour of the traffic lights, and even triple-checking for 
approaching cars to ensure the way was clear. He commented that, “I know that when I drive after 
grog [a common colloquialism for kava], I have to be more careful, so I go through the system”.  
 
Another participant present (a male European in his 30s) added, “True. You have to concentrate 
more. But I can drive OK, but you have to concentrate.” Later in the discussion, the same 
participant warned, “… and never text when you drive after kava. It’s like you get fixed on the 
screen [of the mobile phone] and don’t know time is passing. I almost ran up a car in front”; a 
comment that prompted some teasing from others about the dangers of texting and driving.  
 
When participants were asked what they thought of the brochure, there was overwhelming 
agreement on the value of providing a research summary in a Pacific-flavoured and Pacific-
language-friendly medium. This value has also been recognised by academics. For instance, Hemi 
and Aporosa (2021) explain that translating research “into their own [Pacific] languages” provides 
opportunity for dialogue, accountability and correction (p. 58). They also argue research 
translation is both necessary and complies with ethical standards and research ethic requirements 
(p. 57); “We envision opportunities to check inaccuracies, to corroborate and bear testimony and 
to find consensus, to validate histories and experiences, knowledges and truths. We hope to 
challenge and address histories of assimilation, discrimination and colonisation by education—
and by research.” (p. 58) The reaction of the participants to the Pacific-flavoured and translated 
brochures supports Hemi and Aporosa’s work.  
 




A 33-year-old Fijian male commented that, “This [the brochure] is good. You know us, we don’t 
read things when they long”; suggesting brevity was necessary. A Samoan male in his mid-20s 
typified the comments of several participants when he said, “… people will read this coz it’s in the 
language”; inferring the translated language. A Tongan male in his late-20s asked if he could have 
some to take to the kalapu he typically attended on a Friday night, “for the boys”. 
 
While the aesthetics of the brochures, the content and language friendliness were well 
received and praised by some, their value in prompting immediate behavior change was not as 
encouraging. Participants were asked if they felt the brochures would make them reconsider 
driving following high kava use or defer them from driving. Initially most said ‘yes’, indicating the 
brochures would encourage them to reconsider. However, as the talanoa unfolded, it was clear 
the initial reaction lacked substance. For instance, a Tongan male in his early 30’s commented,  
 
Most of the faikava boys are uneducated so they won’t care, they will just drive. Some might listen 
to the Faifakau [the Minister], just a small percent, so that would be good. And some who know 
someone who dies after driving and faikava might listen. Like me; my cousin died in a crash in Tonga 
after drinking kava. So I know my limit and go home when I’m still safe to drive. That brochure is only 
for a small percent, because most people been driving after kava for years and they will keep doing 
it.  
 
Another Tongan male of similar age added,  
 
Many of the faikava boys come because they have turned away from alcohol [drink kava instead of 
alcohol]. Some of them used to drive after alcohol. They know kava is nothing like alcohol; it doesn’t 
affect driving like alcohol, so they say they are safe to drive. 
 
A Tongan male in his 40s stated,  
 
You can’t teach old dogs new tricks; they will still drive. The way that some might be encouraged to 
think about driving after kava is if you use the Church, get the Faife’au [Minister] to give the message 
and some will listen. I think the hook is the Church. I planned a sports event and the registrations 
were low, so I asked the Faife’au to promote, and we got plenty of people. I think that will be the 
only way, but then some don’t go to Church. 
 
A Tongan male in his early 50s at a kalapu in Canberra stated,  
 
These [brochures] are good for the young boys no good in driving [inferring a lack of driving experience]. I 
live over … [a town approximately an hour’s drive away]. I always come here [to the kalapu] and drink 
[kava] then drive. Sometimes the sun is coming [meaning daybreak] and I drive. I know the way [home]. I 
am good, never have a accident, coz I know the way and I can drive [inferring experience]. 
 




A Samoan male in his mid-20s stated,  
 
This is good information, I understand it [meaning both the content and Samoan language]. But some of 
the younger people won’t understand it coz some of the language is a bit formal. But then that’s the only 
way you can properly convey the message. We Samoan’s don’t drink as much kava as Fijians and Tongans, 
its mostly the older generation [who drink], like the ones in their 60s and then they drive. So this is good 
for them [inferring the language translation for older Samoan kava drinkers]. 
 
The same Samoan male was asked about the value of using of Pacific respect-based values, and 
the suggestion in the brochure that driving after using kava was likely to endanger other road 
users and hence counter to those values. He responded,  
 
Yes, it will make them think. I don’t think there will be dramatic change, but they will be more aware. When 
the older people see this [brochure written in Samoan], they will pick it up straight away, they will like it. 
They will like the values. But the younger people probably won’t read past the first few sentences coz that’s 
young people, they don’t read much, and they aren’t connected to the traditional values the same as the 
older people. 
 
A group of kava drinkers, of mixed Pacific ethnicities and in their early 20s were asked what 
they felt would be the most impacting way to get the kava drink-driving message across to those 
in their age group. A Fijian female suggested,  
 
I think short videos would be the best, about 30 seconds long, coz that’s what they [the younger 
generation] go for. And if you could have influencers in the videos, like rugby hero’s, I think that would get 
the message across.  
 
A Rarotongan female followed with,  
 
I think, you need to come up with something real simple, but a clear message. Like in Rarotonga they ran 
this STD [sexually transmitted disease] campaign, very simple: ‘Did you remember: car keys, wallet, 
condom’ People remembered it and would even say it to each other. Short, simple, good. 
 
Although the brochures appeared to have limited effect in prompting immediate behavior 
change – evidenced in the fact that most of the attendees at the kalapu where the brochures were 
trialed, having consumed kava for 6 hours or more, then drove home – the brochures are 
nevertheless argued to have some value. For example, they led to lengthy talanoa on the effects 
of kava on cognition and driver safety; talanoa, which the author noticed continued over 
subsequent faikava he attended. In addition, the brochures have been requested by kalapu 
attendees and when produced, sparked further talanoa.  
 




Following the trial, a large number of brochures were commercially printed and distributed to 
a variety of Pacific-focused community services, as well as being given to kava users to leave at 
their various kalapu.  
 
Road safety campaign design and evaluation experts Lewis and colleagues (2019) caution the 
need to “dispel the notions of the ‘silver bullet’ and ‘one-size-fits-all’ approach” when it comes to 
promoting driver safety (p. 299). In the case of this study, the focus need not simply be on the 
value of the brochures in curbing problematic kava drink-driving behavior. The talanoa associated 
with the brochures, and the subsequent unpacking of related themes that they stimulate (such as 
discussion around kava’s effects on cognition) are also valuable. As Lewis et al. (2019) state,  
 
To change unsafe behavior is usually a long-term process. It is therefore unrealistic to expect that road 
users will suddenly change their behavior after being exposed to one campaign, especially if the 
behavior has become habitual or if they continue to believe that they will escape any penalty. (p. 312) 
 
Again, in the case of this study and the goal to curb unsafe driving post-kava use, ongoing 
exposure to the brochures is necessary, together with the associated talanoa, as is “the need to 
assess effects over time, including longer-term exposure (i.e., beyond immediate post-exposure 
measures).” (Lewis et al., 2019, p. 312).    
 
 
5. Limitations  
The limitations associated with conducting double-blind placebo-driven research within 
naturalistic kava-use settings have been discussed in several publications (Aporosa 2020; Aporosa 
et al. 2020, 2021).  
 
Aporosa and Tomlinson (2014) comment that, “randomized controlled trials … considered the 
‘gold standard’ for health research … is next to impossible under the conditions in which kava is 
normally consumed” (p. 164). Reasons for this judgement include the cultural significance of kava, 
and the Pacific values associated with its use, which prevent deception by inferring a substance 
was kava when it was not. To do so would be culturally disingenuous and therefore contrary to 
Pacific respect-based values and ideals. In addition, kava research requires experienced kava 
drinkers who can consume typical average kava volumes over 6 hours. Further, experienced kava 
drinkers would immediately recognise a placebo, as kava not only has a unique taste, but also 
produces a tingling in the mouth as a result of selected kavalactones interacting with oral sensory 
nerves; sensations that are difficult to replicate in an inactive substance (Aporosa, 2018a; 2020; 
Aporosa et al., 2014; 2020; 2021).  
 




In addition, knowledge gaps in kava ethnobotany and lactone consistency and distribution 
(AECOM-Kalang, 2017; Bian et al., 2020) add further complications, creating additional gaps in 
current kava understanding. These include gaps in understanding about: 
● kava metabolism and dose relationship (Singh et al., 2004; Bian et al., 2020) 
● kava half-life and elimination (Aporosa et al., 2020) 
● how kavalactones interact with neurophysiological mechanisms (Bwarenaba et al., 
2017) 
● kava reverse tolerance and sensitisation (Aporosa et al., 2020) 
● how to interpret kavalactone levels and elimination in blood samples (Poulsen & 
McCarthy, 2017) 
● the role of “set, and setting” (Zinberg 1986; McElrath & McEvoy, 2002); or how social 
and environmental influences, when combined with how a drug user feels at the time, 
effect kava use across differing environments (Aporosa et al., 2020).  
 
It is likely to be a number of years before many of these limitations have been mitigated, and 
it is for this reason that the World Health Organization has called for more research into all areas 
of kava psychopharmacology, particularly during, following and related to naturalistic kava use 
(Abbott, 2016, p. viii; also see Bian et al., 2020, p. 23).   
 
The author argues, though, that these limitations do not invalidate the learnings from this or 
previous kava drink-driving studies. Kamboj and colleagues (2018) support this claim when they 
comment, 
 
‘naturalistic studies’ (i.e. those conducted in ecological settings) … [may lack the] high levels of 
experimental control afforded by double-blind laboratory studies … [they] are nonetheless potentially 
valuable in allowing efficient preliminary hypothesis testing … [as] these can then pave the way for more 
tightly controlled studies if promising effects are observed. Previous naturalistic drug studies have 
yielded novel findings that were subsequently independently replicated in double-blind laboratory 
experiments. (p. 1135)    
 
  
6 Conclusions and recommendations 
The study and understanding of kava psychopharmacology can be confusing. This is because 
much of the terminology used in ethnographic studies and the media to explain kava’s effects at 
high dose is misleading. Additionally, most research aimed at understanding how kava effects 
cognition and behavior has used tablets or capsules (containing selected extracted kavalactones 
administered at a maximum daily dose of 250mg kavalactones) as part of their methodology (Bian 
et al., 2020; Lim, 2016; Sarris et al., 2011).  
 




Studies such as Sarris and colleagues’ (2013) double-blind, randomised, placebo-controlled 
work, which highlighted the efficacy of small daily doses of tablet-form kava (containing either 
120, 240, or 250mg of kavalactones) in reducing generalised anxiety disorder, have encouraged 
interest in kava’s potential for helping users who ingest a single-tablet dose with a glass of water 
and assert they are taking ‘literal kava’.  
 
As has been explained elsewhere, extracted tablet-form kava is vastly different to kava 
consumed in faikava settings (Aporosa, 2019a; Aporosa et al., 2021). In addition, very little 
research aimed at understanding kava psychopharmacology has been completed using kava as it 
is typically consumed in traditionally influenced settings (Aporosa et al., 2021).  
 
In faikava, users typically sit cross-legged on mats on the floor, often for long periods of time, 
and engage in talanoa (discussion). Faikava attendees usually follow traditionally influenced use 
protocols, in which they prepare a beverage using the dried and pounded rhizome of the kava 
plant, and where each drinker routinely consumes 3.6 litres (7.6 pints) of kava over a 6-hour 
period, while engaging in talanoa and observing (to varing degrees) cultural practices based on 
Pacific respect values.  Kavalactone ingestion volumes at faikava frequently exceed 20 times the 
kavalactone potency administered in kava tablet clinical trials or when kava is given as a medicinal 
aid to reduce anxiety (Aporosa & Tomlinson, 2014). Moreover, kava consumed in these 
traditionally influenced settings contain all the kavalactones, currently believed to number more 
than 20 (Bian et al. 2020), together with some of the fibre and additional minerals from the plant.  
 
Also of significance is that an often-overlooked aspect of any substance use is the associated 
influences and impacts of ‘set and setting’, or a person’s mindset related to the social and physical 
environment of the substance use (Zinberg 1986; McElrath & McEvoy, 2002; Aporosa et al., 2021). 
Nevertheless, kava psychopharmacology understanding is chiefly viewed through the lens of 
inaccurate effect descriptors and research associated with tablet-form kava use, with that latter 
understanding often applied to, or overlaid on, kava users who drink in naturalistic traditionally 
influenced settings.  
 
Further contributing to kava psychopharmacology confusion is the inconsistency and 
subjectivity across studies reporting kava’s impacts on cognition, with some research suggesting 
that kava improves mental function, whereas others state “kava to have little or no negative 
effect on cognitive processes” (Sarris & McIntyre, 2017, p. 16). Again, these studies used tablet-
kava, although the findings have often been interpreted as applying to naturalistic traditionally 
influenced kava users.  
 




Add to this the increasing reports from police of stopping drivers, mostly of Pacific ethnicity, 
who they believe are impaired by kava use, and their limited ability to measure and deal with this; 
and the also increasing anecdotal reports linking kava use with Pacific people’s over-
representation in motor vehicle accident statistics, and it becomes apparent why both the police 
and the New Zealand Institute of Environmental Science and Research have called for research to 
understand the effects of naturalist high-volume kava use on driver safety.   
 
In this second study of its kind, a somatosensory psychometric tool (Brain Gauge) was used to 
measure slight changes in six specific neurological functions – namely Focus, Accuracy, Temporal 
Order Judgement, Timing Perception, Plasticity and Fatigue – during and following faikava. This 
found that following the sixth hour of kava use, at which time each research participant (n=20) 
had consumed 3.6 litres of beverage kava equating to 3,680mg of kavalactones (or 14 times the 
pharmacologically recommended dose), there was no statistically significant impact on the Focus, 
Accuracy, Timing Perception, Plasticity or Fatigue of the active kava user, when compared against 
the control group (n=19). 
 
However, analysis of within group data (which compared active kava users with each other) 
found that between the third and sixth hour of testing, these kava drinking participants showed 
a small improvement in their Focus (and Fatigue), despite being at the test venue for over 6 hours 
and the final test not being conducted until 12.30am. This slight improvement was unexpected, 
particularly as kava’s dominant effects are reported as soporific, anxiolytic and relaxant. 
Additionally, while this finding would suggest increased driver alertness overall, and therefore 
improved driving safety, the data showed a very different effect on participants’ Temporal Order 
Judgement.  
 
Temporal Order Judgement, or “how well [the] brain is able to keep track of the order of 
events” (Pawluk, 2018e), which is associated with a person’s executive function, was shown to be 
(strongly) statistically impaired when compare with the control group. This is both a unique and 
new finding, and suggests kava at traditionally consumed volumes compromises driver safety, 
although the nature of this impairment is vastly different to alcohol, cannabis, and other euphoric 
and hallucinogenic substances. The findings also add quantitative understanding to ethnographic 
data on kava effects, suggesting the often-used term ‘kava intoxication’ is misleading and 
incorrect. 
   
Although this study generated new neurophysiological understanding concerning kava use, it 
also further highlights the huge knowledge gap that exists concerning kava psychopharmacology. 
That knowledge gap is demonstrated in the lack of interpretation of much of the study data, 
particularly around how kava impacts on selected cognitive facilities but not others. That 




understanding is not likely to advance until, at a minimum, “the neurophysiological mechanisms 
associated with kavalactone metabolism” (Bwarenaba et al., 2017, p. 5) when consumed at 
traditionally influenced use volumes, are understood. That lack of understanding essentially 
hampers further kava drink-driving research, except for learnings likely to derive from testing kava 
users in a driving simulator.  
 
That lack of understanding also hampers road policing, particularly as the interpretation of 
kavalactones in blood tests, and therefore the ability to use blood samples for evidentiary 
purposes, is linked to understandings of the “neurophysiological mechanisms associated with 
kavalactone metabolism”. Further, with kava not metabolising on the breath in a similar manner 
to alcohol, therefore excluding current breath-test measures, it is likely to be some time before 
road policing has suitable evidential-standard measures to assess kava drink-driver competency. 
When it comes to alcohol, such measures are considered “the most effective way to deter drink-
driving” (Smith, 2013, p. 24). 
 
The study also tested the value of a Pacific-flavoured, valued and language-friendly brochure 
aimed at providing kava drink-driving education to curb unsafe post-kava driving. While the 
brochure was well received and prompted a lot of talanoa about the effects of kava on cognition 
and experiences of post-kava-drinking driving, immediate changes to participants’ behaviour 
appeared limited. Drawing on road campaign design and evaluation work by Lewis and colleagues 
(2019), long-term exposure to this brochure and its associated information is recommended as 
required before an impact can be expected.   
 
This study has nevertheless made a major contribution to kava neuroscientific understanding, 
particularly in relation to neuro-psychopharmacology. The study has highlighted the need for 
more research in understanding the effects of kava when consumed at traditionally influenced 
volumes. The study also responds to the World Health Organization's call for more understanding 
on kava psychopharmacology related to traditionally influenced use volumes, and Watson and 
Mann’s (2018) request for more research and understanding on the “social [and] cultural … 
patterns of [drug impaired driving … and the] many types of psychoactive substance use (licit and 
illicit, recreational and therapeutic) that can impair driving” (p. 107). 
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Appendix A: Simple box-plot showing the results of the Accuracy data 
 












Appendix C: Simple box-plot showing the results of the Plasticity data 
 
 




Appendix D: Simple box-plot showing the results of the Fatigue data 
 
 






















   
 














   
 




Appendix H: Cover and inside of Samoan language kava drink-driving brochure  
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
